Clinical Therapeutic and Management Strategies for Epilepsy
Deadline for manuscript submissions: 3 July 2024 | Viewed by 2830
The quality of life (QOL) of children suffering from childhood epilepsy may be associated with clinical and social variables. Among these variables, seizure severities, including frequent seizures and status epileptics, have been identified as important predictors of QOL. In addition, frequent interictal epileptiform discharges (IEDs) on EEG may also accompany transient cognitive/behavioral impairments. Moreover, frequent seizures and/or IEDs may play a role as mediators of emotional responses including stigma and fatigue. Thus, seizure severities and IEDs are important QOL-related factors. Though children with epilepsy do not always exhibit neuropsychological problems, seizure severities and IEDs on EEG may be associated with neuropsychological impairments. To prevent these disturbances, we should appropriately treat patients to suppress seizures and EEG abnormalities as early as possible. The optimal treatment strategy should be chosen to mitigate seizures and EEG abnormalities as soon as possible and accomplish the most favorable prognosis for children with epilepsy. There is thus a need for the development of antiseizure medications with novel mechanisms of action that have the potential to improve outcomes. This Special Issue aims to highlight recent advances in the context of QOL-related factors, treatment, and the therapeutic management and strategies for children with epilepsy.
Dr. Hideaki Kanemura
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- quality of life (QOL)
- seizure severity
- interictal epileptiform discharge (IED)
- antiseizure medication